Bellicum Pharmaceuticals Financials

Bellicum Pharmaceuticals Stock Summary

Bellicum Pharmaceuticals competes with Cellectis, Adaptimmune Therapeutics, Atara Biotherapeutics, and Affimed NV. Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. Bellicum Pharmaceuticals, Inc. was incorporated in 2004 and is headquartered in Houston, Texas. Bellicum Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 7 people.

Bellicum Pharmaceuticals Key Financial Ratios

There are many critical financial ratios that Bellicum Pharmaceuticals' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Bellicum Pharmaceuticals reports annually and quarterly.

Bellicum Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Bellicum Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Bellicum Pharmaceuticals value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bellicum Pharmaceuticals competition to find correlations between indicators driving Bellicum Pharmaceuticals's intrinsic value. More Info.Bellicum Pharmaceuticals is rated third in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Bellicum Pharmaceuticals' earnings, one of the primary drivers of an investment's value.

Bellicum Pharmaceuticals Market Pulse

Along with financial statement analysis, the daily predictive indicators of Bellicum Pharmaceuticals help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Bellicum Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Bellicum Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Bellicum Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Bellicum Pharmaceuticals's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

If you are still planning to invest in Bellicum Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bellicum Pharmaceuticals' history and understand the potential risks before investing.